NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)- Newspaper Publication12-01-2022
12-01-2022
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for For Considering And Approving The Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2021
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 202107-01-2022
NEULAND LABORATORIES LTD. - 524558 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sarada BhamidipatiDesignation :- Company Secretary and Compliance Officer07-01-2022
NEULAND LABORATORIES LTD. - 524558 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201807-01-2022
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)- Newspaper Publication07-01-2022
NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 201530-12-2021
NEULAND LABORATORIES LTD. - 524558 - Reporting Under SEBI (Prohibition Of Insider Trading) Regulations, 2015
Reporting under SEBI (Prohibition Of Insider Trading) Regulations, 201527-12-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Analysts / Institutional Investor Meet - Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201510-12-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Demise
With deep regret, we wish to inform you that the Company was intimated today about the sad demise of Dr.William Gordon Mitchell (02222567), Non-Executive Independent Director of the Company. Dr.Will Mitchell passed away on December 6, 2021. Dr. Mitchell was on the Board of the Company since 2008 and the Company immensely benefitted from his vision and contribution during his tenure. All the Directors and employees of the Company convey deep sympathy, sorrow and condolences to his family. You are requested to kindly take the above information on your records.10-12-2021